USD29.64
Frontiers | N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) 2020;217:e20192195 https://ars.els-cdn.com/content/image/1-s2.0-S2590257124000336-gr1.jpg B2B market mg:5mg
USD29.64
USD27.02
USD22.88
Keep missing information visible instead of filling it with guesses. Use the table to support judgment rather than replace it.
Consider whether an acceptable alternative could meet the same purpose. Avoid allowing a short deadline to erase an essential requirement.
Use a cropped view when it fully supports your intended point. Keep enough context to avoid misrepresenting the information shown.